Share Graph – Esperite

Search for:

Share Graph

Search for:

ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
Esperite (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.
ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
ESPERITE NV (ESP) AND PBKM (FAMICORD GROUP) SIGN EXCLUSIVE AGREEMENT REGARDING POTENTIAL ACQUISITION OF CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS.
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 24th tranche of investment today

Esperite N.V. - Herengracht 282
1016 BX Amsterdam - The Netherlands

Tel. +31 (0) 575 548 998
Email: ir@esperite.com